Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Clinical trials begin with topical impotence treatment

Sep. 23, 1997

BM-41.0904: a potential new osteoanabolic agent

Sep. 23, 1997

New SERMs prepared at Lilly

Sep. 23, 1997

Abbott searches for squalene synthase inhibitors as hypolipidemics

Sep. 23, 1997

Novel progestins described by Gedeon Richter

Sep. 23, 1997

Levormeloxifene preclinical and clinical data presented

Sep. 22, 1997

Additional PLAs filed for INVICORP

Sep. 22, 1997

Eel calcitonin nasal spray evaluated in phase I

Sep. 22, 1997

Calcimimetic agent shown active in preclinical models of hyperparathyroidism

Sep. 22, 1997

Tiqueside inhibits cholesterol absorption and reduces LDL cholesterol in humans

Sep. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...